Abstract
Glucose-6-phosphate (G6P) transporters are crucial for glucose metabolism by mediating G6P transport from the cytoplasm to endoplasmic reticulum (ER). However, their transport mechanisms remain poorly understood. Here, we elucidate the structural and functional basis of human solute carrier family 37 member 2 (SLC37A2), a G6P transporter implicated in metabolic regulation and macrophage inflammation. We show that SLC37A2 functions as a uniporter, facilitating G6P transport independent of inorganic phosphate gradients. Structures of SLC37A2 in the apo and G6P-bound states reveal a dimeric architecture. Both the ER luminal-open and cytosolic-open structures are captured, showing the structural dynamics during G6P transport. G6P is coordinated by SLC37A2 through interactions with its phosphate and hydroxyl groups. Furthermore, mapping mutations associated with glycogen storage disease type Ib onto SLC37A2 highlights residues essential for transport activity. Together, this work provides structural insights into G6P transport and establishes a framework for understanding related metabolic disorders.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
Data availability
Model coordinates and cryo-EM density maps for the apo, luminal-open state SLC37A2apo, LO, the G6P-unbound, luminal-open state SLC37A2G6P, LO, the G6P-bound cytosolic-open state SLC37A2G6P, CO and the asymmetric state SLC37A2G6P, LO+CO were deposited to the PDB under accession codes 9UCM, 9UDX, 9UDW and 9UDV and the EM Data Bank under accession codes EMD-64048, EMD-64074, EMD-64073 and EMD-64072, respectively. Data and materials can be obtained from the corresponding authors upon request. Source data are provided with this paper.
References
Rajas, F., Gautier-Stein, A. & Mithieux, G. Glucose-6 phosphate, a central hub for liver carbohydrate metabolism. Metabolites 9, 282 (2019).
Lizák, B. et al. Glucose transport and transporters in the endomembranes. Int. J. Mol. Sci. 20, 5898 (2019).
Marcolongo, P. et al. Multiple roles of glucose-6-phosphatases in pathophysiology: state of the art and future trends. Biochim. Biophys. Acta 1830, 2608–2618 (2013).
Arion, W. J., Walls, B. K., Lange, A. J. & Ballas, L. M. On the involvement of a glucose 6-phosphate transport system in the function of microsomal glucose 6-phosphatase. Mol. Cell. Biochem. 6, 75–83 (1975).
Csala, M. et al. Transport and transporters in the endoplasmic reticulum. Biochim. Biohpys. Acta 1768, 1325–1341 (2007).
Gerin, I., Veiga-da-Cunha, M., Achouri, Y., Collet, J. F. & Van Schaftingen, E. Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib. FEBS Lett. 419, 235–238 (1997).
Hiraiwa, H., Pan, C. J., Lin, B. C., Moses, S. W. & Chou, J. Y. Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. J. Biol. Chem. 274, 5532–5536 (1999).
Chou, J. Y., Jun, H. S. & Mansfield, B. C. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes. J. Inherit. Metab. Dis. 38, 511–519 (2015).
Annabi, B. et al. The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am. J. Hum. Genet. 62, 400–405 (1998).
Ihara, K., Nomura, A., Hikino, S., Takada, H. & Hara, T. Quantitative analysis of glucose-6-phosphate translocase gene expression in various human tissues and haematopoietic progenitor cells. J. Inherit. Metab. Dis. 23, 583–592 (2000).
Arion, W. J., Carlson, P. W., Lange, A. J. & Wallin, B. K. The specificity of glucose 6-phosphatase of intact liver microsomes. J. Biol. Chem. 247, 2558–2565 (1972).
Arion, W. J., Ballas, L. M., Lange, A. J. & Wallin, B. K. Microsomal membrane permeability and the hepatic glucose-6-phosphatase system. Interactions of system with D-Mannose 6-phosphate and D-mannose. J. Biol. Chem. 251, 4891–4897 (1976).
Arion, W. J., Lange, A. J., Walls, H. E. & Ballas, L. M. Evidence for the participation of independent translocases for phosphate and glucose-6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the System with orthophosphate, inorganic pyrophosphate, and carbamyl-phosphate. J. Biol. Chem. 255, 10396–10406 (1980).
Cappello, A. R., Curcio, R., Lappano, R., Maggiolini, M. & Dolce, V. The physiopathological role of the exchangers belonging to the SLC37 family. Front. Chem. 6, 122 (2018).
Shieh, J. J., Pan, C. J., Mansfield, B. C. & Chou, J. Y. A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia. J. Biol. Chem. 278, 47098–47103 (2003).
Chou, J. Y., Cho, J. H., Kim, G. Y. & Mansfield, B. C. Molecular biology and gene therapy for glycogen storage disease type Ib. J. Inherit. Metab. Dis. 41, 1007–1014 (2018).
Sim, S. W., Weinstein, D. A., Lee, Y. M. & Jun, H. S. Glycogen storage disease type Ib: role of glucose-6-phosphate transporter in cell metabolism and function. FEBS Lett. 594, 3–18 (2020).
Chen, L. Y., Lin, B. C., Pan, C. J., Hiraiwa, H. & Chou, J. Y. Structural requirements for the stability and microsomal transport activity of the human glucose 6-phosphate transporter. J. Biol. Chem. 275, 34280–34286 (2000).
Chen, L. Y., Pan, C. J. & Chou, J. Y. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib. Hum. Mol. Genet. 11, 3199–3207 (2002).
Pan, C. J. et al. The signature motif in human glucose-6-phosphate transporter is essential for microsomal transport of glucose-6-phosphate. Hum. Genet. 112, 430–433 (2003).
Ahn, H. H. et al. Identification of glucose-6-phosphate transporter as a key regulator functioning at the autophagy initiation step. FEBS Lett. 589, 2100–2109 (2015).
Jeon, Y. G., Kim, Y. Y., Lee, G. & Kim, J. B. Physiological and pathological roles of lipogenesis. Nat. Metab. 5, 735–759 (2023).
Chou, J. Y., Jun, H. S. & Mansfield, B. C. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat. Rev. Endocrinol. 6, 676–688 (2010).
Belkaid, A., Copland, I. B., Massillon, D. & Annabi, B. Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin. FEBS Lett. 580, 3746–3752 (2006).
Pao, S. S., Paulsen, I. T. & Saier, M. H. Major facilitator superfamily. Microbiol. Mol. Biol. Rev. 62, 1–34 (1998).
Bartoloni, L. & Antonarakis, S. E. The human sugar-phosphate/phosphate exchanger family SLC37. Pflugers Arch. 447, 780–783 (2004).
Chou, J. Y. & Mansfield, B. C. The SLC37 family of sugar-phosphate/phosphate exchangers. Curr. Top. Membr. 73, 357–382 (2014).
Kim, J. Y., Tillison, K., Zhou, S., Wu, Y. & Smas, C. M. The major facilitator superfamily member Slc37a2 is a novel macrophage- specific gene selectively expressed in obese white adipose tissue. Am. J. Physiol. Endocrinol. Metab. 293, E110–E120 (2007).
Wang, Z. et al. Solute carrier family 37 member 2 (SLC37A2) negatively regulates murine macrophage inflammation by controlling glycolysis. iScience 23, 101125 (2020).
Zhao, Q. et al. Hematopoietic cell-specific SLC37A2 deficiency accelerates atherosclerosis in LDL receptor-deficient mice. Front. Cardiovasc. Med. 8, 777098 (2021).
Ng, P. Y. et al. Sugar transporter Slc37a2 regulates bone metabolism in mice via a tubular lysosomal network in osteoclasts. Nat. Commun. 14, 906 (2023).
Wilfinger, J. et al. Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system. J. Nutr. Biochem. 25, 875–884 (2014).
Saksa, N. et al. Dissecting high from low responders in a vitamin D3 intervention study. J. Steroid Biochem. Mol. Biol. 148, 275–282 (2015).
Iskarpatyoti, J. A. et al. Mast cell regranulation requires a metabolic switch involving mTORC1 and a glucose-6-phosphate transporter. Cell Rep. 40, 111346 (2022).
Villani, A. et al. Clearance by microglia depends on packaging of phagosomes into a unique cellular compartment. Dev. Cell 49, 77–88.e7 (2019).
Zilberstein, D. et al. SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate a. PLoS ONE 6, e23157 (2011).
Chen, S.-Y. et al. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic. FASEB J. 22, 2206–2213 (2008).
Marcolongo, P. et al. The glucose-6-phosphate transport is not mediated by a glucose-6-hosphate/phosphate exchange in liver microsomes. FEBS Lett. 586, 3354–3359 (2012).
Arion, W. J. et al. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch. Biochem. Biophys. 339, 315–322 (1997).
Pan, C. J., Lin, B. C. & Chou, J. Y. Transmembrane topology of human glucose 6-phosphate transporter. J. Biol. Chem. 274, 13865–13869 (1999).
Yan, N. Structural biology of the major facilitator superfamily transporters. Annu. Rev. Biophys. 44, 257–283 (2015).
Kumari, M., Balaji, P. V. & Sunoj, R. B. Quantification of binding affinities of essential sugars with a tryptophan analogue and the ubiquitous role of C–H···π interactions. Phys. Chem. Chem. Phys. 13, 6517–6530 (2011).
Sun, L. F. et al. Crystal structure of a bacterial homologue of glucose transporters GLUT1-4. Nature 490, 361–366 (2012).
Deng, D. et al. Molecular basis of ligand recognition and transport by glucose transporters. Nature 526, 391–396 (2015).
Qureshi, A. A. et al. The molecular basis for sugar import in malaria parasites. Nature 578, 321–325 (2020).
Bavnhoj, L., Paulsen, P. A., Flores-Canales, J. C., Schiott, B. & Pedersen, B. P. Molecular mechanism of sugar transport in plants unveiled by structures of glucose/H+ symporter STP10. Nat. Plants 7, 1409–1419 (2021).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Bavnhoj, L. et al. Structure and sucrose binding mechanism of the plant SUC1 sucrose transporter. Nat. Plants 9, 938–950 (2023).
Paulsen, P. A., Custódio, T. F. & Pedersen, B. P. Crystal structure of the plant symporter STP10 illuminates sugar uptake mechanism in monosaccharide transporter superfamily. Nat. Commun. 10, 407 (2019).
Ying, W. et al. Structure and function of the Arabidopsis ABC transporter ABCB19 in brassinosteroid export. Science 383, eadj4591 (2024).
Yang, Z. S. et al. Structural insights into auxin recognition and efflux by PIN1. Nature 609, 611–615 (2022).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Rosenthal, P. B. & Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721–745 (2003).
Chen, S. X. et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy 135, 24–35 (2013).
Pettersen, E. F. et al. UCSF chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).
Acknowledgements
We thank the Cryo-EM Center of the University of Science and Technology of China for the EM facility support. This work was supported by the National Natural Science Foundation of China (32471279 to X.L. and 32322041, 32321001 and W2412029 to L.S.), the Scientific Research Innovation Capability Support Project for Young Faculty (ZYGXQNJSKYCXNLZCXM-B8 to L.S.), Center for Advanced Interdisciplinary Science and Biomedicine of IHM (QYPY20230034 to L.S.), Natural Science Foundation of Anhui Province (2408085JX005 to L.S.), Fundamental Research Funds for the Central Universities (WK9100000031 to L.S. and WK9100000065 to Z.Y.) and USTC Research Funds of the Double First-Class Initiative (YD9100002004 to L.S. and YD9100002020 to X.L.). L.S. is supported by the Outstanding Young Scholar Award from the Qiu Shi Science and Technologies Foundation. X.L. and L.S. are supported by the Young Scholar Award from the Cyrus Tang Foundation.
Author information
Authors and Affiliations
Contributions
X.L. and L.S. conceptualized the project. X.L. and L.S. designed the experiments and analyzed the data. Q.L. and M.X. performed the molecular cloning and protein purification work. Q.L., M.X. and Z.Y. performed the transport assays. Q.L., Z.Y. and Y.G. performed the cryo-EM data collection. Q.L. and Z.Y. performed the cryo-EM data processing and model building. Q.L., L.S. and X.L. wrote the manuscript. All authors revised the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Structural & Molecular Biology thanks the anonymous reviewers for their contribution to the peer review of this work. Peer reviewer reports are available. Primary Handling Editor: Katarzyna Ciazynska, in collaboration with the Nature Structural & Molecular Biology team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Sequence alignment and phylogenetic tree plotting for SLC37 family members.
a, Sequence alignment of Homo sapiens SLC37A1, SLC37A2, SLC37A3, and SLC37A4. The transmembrane (TM) domains, H0, and H13 helixes of SLC37A2 are indicated above the sequences. The G6P interacting residues are indicated above the sequences with stars (★). The natural mutation sites in SLC37A4 associated with diseases are indicated below the sequences with asterisks (*). b, The percent identity matrix of the human SLC37 family transporters. Sequence identities were calculated using the alignment tool in UniProt (https://www.uniprot.org/align). c, Phylogenetic tree of human SLC37 family members constructed with the program iTOL v7 (https://itol.embl.de/). Protein sequences of SLC37A1 (UniProt ID: P57057), SLC37A2 (UniProt ID: Q8TED4), SLC37A3 (UniProt ID: Q8NCC5), SLC37A4 (UniProt ID: O43826) were acquired from UniProt (https://www.uniprot.org/).
Extended Data Fig. 2 Protein purification and transport analyses of SLC37A2 and SLC37A4.
a, The size exclusion chromatography (SEC) profiles of wild-type SLC37A2 and SLC37A4 (SLC37A2WT and SLC37A4WT) purified from HEK293F cells, and the SEC profiles of SLC37A2WT and the N-terminal truncation mutant (1-13 aa) SLC37A2ΔN expressed in HEK293F cells. b, PNGase F treatment results of SLC37A2WT, SLC37A2ΔN, SLC37A4WT proteins. The representative SDS-PAGE result of the proteins prior to and after PNGase F treatment is shown here. The experiments were repeated independently at least three times with similar results. c, G6P transport activities of SLC37A2WT and SLC37A4WT assessed using a proteoliposome-based 3H-G6P transport assay with phosphate buffer (50 mM KH2PO4, pH 7.0, 1 mM DTT, and the protease cocktails) as the inner buffer and MOPS/K buffer (20 mM MOPS, pH 7.5, 75 mM K2SO4, 2.5 mM MgSO4, 1 mM DTT, and the protease cocktails) as the exterior buffer. The data are presented as mean ± SD (n = 3 biologically independent repeats). Significances of the SLC37A2 and SLC37A4 groups versus the control group were determined using a two-tailed unpaired t-test. **** P < 0.0001. The other exact P value was labeled above the column. d, Glucose transport activities of the SLC37A2WT and SLC37A4WT proteins assessed via a proteoliposome-based 3H-glucose transport assay in which HEPES/Na buffer (25 mM HEPES, pH 7.4, 150 mM NaCl) was used as the interior and exterior buffer. The data are presented as the mean ± SD (n = 3 biologically independent repeats). Significances of the SLC37A2 and SLC37A4 groups versus the control group were determined using a two-tailed unpaired t-test. The exact P values were labeled above the columns. e, Chemical structures of chlorogenic acid (CHA), vanadate and inorganic phosphate (Pi). f, Chemical structures of the sugars and sugar phosphates used in the 3H-G6P competition assay.
Extended Data Fig. 3 Cryo-EM analyses of SLC37A4apo and SLC37A2apo.
a, A typical cryo-EM micrograph of SLC37A4 in the apo state (SLC37A4apo). 4078 micrographs were obtained with similar results. b, Representative 2D classification images of SLC37A4apo. c, The low-resolution cryo-EM map resolved for SLC37A4apo. d, A typical cryo-EM micrograph of SLC37A2 in the apo state (SLC37A2apo). 1903 micrographs were obtained with similar results. e, Selected fine 2D classification images of SLC37A2apo. f, Local resolution map of SLC37A2apo. g, Gold-standard Fourier shell correlation curves for the overall EM map of SLC37A2apo. h, Euler angle distributions of SLC37A2apo.
Extended Data Fig. 4 Flowchart for the data processing of SLC37A2 in the apo state and the structural analyses of SLC37A2.
a, Flowchart for the data processing SLC37A2 in the apo state (SLC37A2apo). b, EM densities of the twelve transmembrane helices of the SLC37A2apo, LO map. Residues with notable side chains are labelled. c, Structural superposition of the N-domain and C-domain of SLC37A2 structure. d, Characteristic MFS-fold observed in the SLC37A2 structure.
Extended Data Fig. 5 Cryo-EM analyses of SLC37A2 in the presence of G6P.
a, A typical cryo-EM micrograph of SLC37A2 in the presence of G6P (SLC37A2G6P). 3170 micrographs were obtained with similar results. b, Representative 2D classification images of SLC37A2G6P. c, Local resolution map of SLC37A2G6P, LO. d, Gold-standard Fourier shell correlation curves for the overall map of SLC37A2G6P, LO. e, Euler angle distributions of SLC37A2G6P, LO. f, Local resolution map of SLC37A2G6P, CO. g, Gold-standard Fourier shell correlation curves for the overall map of SLC37A2G6P, CO. h, Euler angle distributions of SLC37A2G6P, CO. i, Local resolution map of SLC37A2G6P, LO+CO. j, Gold-standard Fourier shell correlation curves for the overall map of SLC37A2G6P, LO+CO. k, Euler angle distributions of SLC37A2G6P, LO+CO.
Extended Data Fig. 6 Flowchart for the data processing of SLC37A2 in the presence of G6P.
Details can be found in the imaging processing section in Methods.
Extended Data Fig. 7 EM densities of the transmembrane helices in the symmetric SLC37A2G6P, LO and SLC37A2G6P, CO maps.
a, EM densities of the twelve transmembrane helices of the symmetric SLC37A2G6P, LO map. Residues with notable side chains are labelled aside. b, EM densities of the twelve transmembrane helices of the symmetric SLC37A2G6P, CO map. Residues with notable side chains are labelled aside.
Extended Data Fig. 8 EM densities of the transmembrane helices in the asymmetric SLC37A2G6P, LO+CO map.
a, EM density maps of the twelve transmembrane helices of the ER luminal-open protomer in the asymmetric SLC37A2G6P, LO+CO structure. Residues with notable side chains are labelled aside. b, EM density maps of the twelve transmembrane helices of the cytosolic-open protomer in the asymmetric SLC37A2G6P, LO+CO structure. Residues with notable side chains are labelled aside.
Extended Data Fig. 9 Sugar binding site in SLC37A2 and structural mapping of the SLC37A4 mutations related to human GSD-Ib disease.
a, Sugar binding site in SLC37A2 and the sugar transporter homologues of the MFS superfamily. The N-domain and C-domain of SLC37A2 and the sugar transporter homologues are in different colours. The bound G6P and glucose (Glc) molecules are shown in sticks. The PDB accession codes are indicated for the homologue structures. b, Structural superposition of glucose-bound human GLUT3 (hGLUT3) and G6P-bound SLC37A2. c, Missense mutations in SLC37A4 that cause human GSD-Ib disease mapped to the predicted SLC37A4 structure using AlphaFold2 and the corresponding mutations in the determined G6P-bound SLC37A2 structure. Mutations are shown in slate spheres. Conserved sites within SLC37A4 and SLC37A2 are coloured white. Conserved sites involved in G6P binding in SLC37A2G6P, CO are coloured red. d, 3H-G6P transport by SLC37A2WT and selected mutants corresponding to those in SLC37A4 which are associated with GSD-Ib disease. Net 3H-G6P accumulations of the mutants calculated by deleting the 3H-G6P accumulation of the control group were normalized to the net accumulation of SLC37A2WT. Data are means ± SD (n = 3 biologically independent repeats). Significances of the mutants versus wild-type (WT) were evaluated using one-way ANOVA with Dunnett’s multiple comparisons test. **** P < 0.0001. e, Side-view of the mutations corresponding to those disease-related residues in SLC37A2 near the G6P binding site in SLC37A2G6P, CO. f, Top-view of the mutations corresponding to those disease-related residues in SLC37A2 near the G6P binding site in SLC37A2G6P, CO. g, G403 residue in the SLC37A2 luminal- and cytosolic-open conformations.
Supplementary information
Source data
Source Data Fig. 1
Statistical source data.
Source Data Fig. 2
Statistical source data.
Source Data Fig. 3
Statistical source data.
Source Data Fig. 4
Statistical source data.
Source Data Extended Data Fig. 2
Unprocessed gel.
Source Data Extended Data Fig. 2
Statistical source data.
Source Data Extended Data Fig. 9
Statistical source data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lai, Q., Xu, M., Gao, Y. et al. Structural basis of glucose-6-phosphate transport by human SLC37A2. Nat Struct Mol Biol 33, 112–122 (2026). https://doi.org/10.1038/s41594-025-01712-4
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41594-025-01712-4


